PUBLISHER: The Business Research Company | PRODUCT CODE: 1946594
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946594
Neurology diagnostic and monitoring devices evaluate disorders of the brain, spinal cord, and nerves, helping detect conditions such as epilepsy, stroke, Alzheimer's disease, and multiple sclerosis.
The main device categories of neurology diagnostic and monitoring devices include electroencephalogram (EEG) systems, magnetic resonance imaging (MRI) systems, computed tomography (CT) scanners, positron emission tomography (PET) systems, ultrasound imaging systems, and others. EEG systems are devices that detect and record electrical activity in the brain using electrodes placed on the scalp. These systems are used for conditions such as neurodegenerative disorders, epilepsy, stroke, and others. The end users include hospitals and surgical centers, neurology centers, ambulatory care centers, diagnostic laboratories and imaging centers, as well as academic institutions.
Tariffs have influenced the neurology diagnostic and monitoring devices market by raising costs of imaging components, semiconductors, and precision electronics, particularly affecting MRI, CT, and PET systems in Asia-Pacific and Europe. These impacts have slowed procurement cycles for hospitals and diagnostic labs. However, tariffs have encouraged localized assembly, regional partnerships, and supply chain diversification.
The neurology diagnostic and monitoring devices market research report is one of a series of new reports from The Business Research Company that provides neurology diagnostic and monitoring devices market statistics, including neurology diagnostic and monitoring devices industry global market size, regional shares, competitors with a neurology diagnostic and monitoring devices market share, detailed neurology diagnostic and monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurology diagnostic and monitoring devices industry. This neurology diagnostic and monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The neurology diagnostic and monitoring devices market size has grown strongly in recent years. It will grow from $9.32 billion in 2025 to $10.19 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising neurological disorder prevalence, growth in imaging infrastructure, advancements in EEG and MRI systems, increased hospital diagnostics, aging population.
The neurology diagnostic and monitoring devices market size is expected to see strong growth in the next few years. It will grow to $14.38 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to demand for remote patient monitoring, expansion of neurology centers, increasing awareness of brain health, technological advancements in imaging, rising research investments. Major trends in the forecast period include increasing use of portable neurology devices, growing demand for early disease diagnosis, expansion of remote neurological monitoring, rising adoption of non-invasive diagnostic tools, growth in multimodal imaging approaches.
The increasing prevalence of neurodegenerative diseases is increasingly supporting the expansion of the neurology diagnostic and monitoring devices market going forward. Neurodegenerative diseases are characterized by the progressive loss of neuron structure and function in the brain and spinal cord, leading to cognitive and motor decline. The growing prevalence of these conditions is linked to aging populations, longer life expectancy, and increased exposure to genetic and environmental risk factors. Neurology diagnostic and monitoring devices provide real-time and precise assessment of neurological function and disease progression, enabling early diagnosis, personalized treatment planning, and effective monitoring of therapeutic responses. For example, in April 2025, according to the Alzheimer's Association, a US-based nonprofit organization, more than 7 million Americans were living with Alzheimer's disease, with projections indicating this number could approach 13 million by 2050. As a result, the rising prevalence of neurodegenerative diseases is reinforcing growth within the neurology diagnostic and monitoring devices market.
Leading companies operating in the neurology diagnostic and monitoring devices market are focusing on advanced solutions such as image-guided therapy systems to improve precision in neurovascular interventions. Image-guided therapy systems support real-time planning, navigation, and execution of therapeutic procedures. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, launched the Azurion neuro biplane system. This platform enhances minimally invasive diagnosis and treatment of neurovascular conditions through advanced imaging flexibility, rapid switching between 2D and 3D views, table-side controls for sterile workflow maintenance, automated beam rotation, and AI-enabled performance monitoring.
In January 2024, Aditxt, Inc., a US-based healthcare company, acquired proprietary EEG monitoring technologies, including NeuroCap and NeuroEEG, from Brain Scientific, Inc. for an undisclosed amount. With this acquisition, Aditxt sought to expand into neurology diagnostics and monitoring by integrating telehealth-enabled EEG systems capable of streamlining testing and interpretation in remote and critical-care environments. Brain Scientific is a US-based provider of neurology diagnostic and monitoring devices.
Major companies operating in the neurology diagnostic and monitoring devices market are Siemens Healthineers, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Shimadzu Corporation, Masimo Corporation, Nihon Kohden Corporation, Elekta AB, Natus Medical Incorporated, Esaote S.p.A., Zynex Medical Inc., Canon Medical Systems Corporation, Neurosoft S.A., Cadwell Industries Inc., Cogito Brains Inc., Blackrock Neurotech Inc., Compumedics Limited, Ceribell Inc., Nexstim Plc, NeuroMetrix Inc., Lumos Labs Inc., Soterix Medical Inc., Advanced Brain Monitoring Inc., Sense Neuro Diagnostics Inc.
North America was the largest region in the neurology diagnostic and monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurology diagnostic and monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the neurology diagnostic and monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The neurology diagnostic and monitoring devices market consists of sales of electromyography (EMG) systems, magnetoencephalography (MEG) systems, functional magnetic resonance imaging (fMRI) systems, and transcranial magnetic stimulation (TMS) systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neurology Diagnostic And Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses neurology diagnostic and monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for neurology diagnostic and monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurology diagnostic and monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.